1996

  1. B.J. Kuss, R.G. Deeley, S.P.C. Cole, C.L. Willman, K.J. Kopecky, S.R. Wolman, H.I. Eyre and D.F. Callen. The biological significance of the multidrug resistance gene MRP in inversion 16 leukaemias. Leuk. Lymph. 20: 357-364 (1996).
  2. D.D. Ross, L.A. Doyle, C.A. Schiffer, E.J. Lee, C.E. Grant, S.P.C. Cole, R.G. Deeley, W. Yang and Y. Tong. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia 10: 48-55 (1996).
  3. I. Leier, G. Jedlitschky, U. Buchholz, M. Center, S.P.C. Cole, R.G. Deeley and D. Keppler. ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 34: 433-437 (1996).
  4. S.P.C. Cole. Multidrug resistance in human lung cancer and topoisomerase II. In, Lung Cancer: Principles and Practice (eds. H.I. Pass, J.B. Mitchell, D.H. Johnson and A.T. Turrisi). Chapter 12, pp. 169-204, Lippincott-Raven, Philadelphia (1996). (invited)
  5. A.J. Stewart, Y. Canitrot, E. Baracchini, N.M. Dean, R.G. Deeley and S.P.C. Cole. Reduction in expression of the multidrug resistance protein, MRP, in human tumour cells by antisense phosphorothioate oligonucleotides. Biochem. Pharmacol. 51: 461-469 (1996).
  6. D.W. Loe, K.C. Almquist, R.G. Deeley and S.P.C. Cole. Multidrug Resistance Protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271: 9675-9682 (1996).
  7. D.W. Loe, K.C. Almquist, S.P.C. Cole and R.G. Deeley. ATP-Dependent 17 -estradiol 17-( -D-glucuronide) transport by Multidrug Resistance Protein (MRP): Inhibition by cholestatic steroids. J. Biol. Chem. 271: 9683-9689 (1996).
  8. D.W. Loe, R.G. Deeley and S.P.C. Cole. Biology of drug resistance associated with overexpression of the multidrug resistance protein, MRP. Eur. J. Cancer 32A: 945-957 (1996) (invited, peer-reviewed).
  9. B.D. Stride, G. Valdimarsson, J.H. Gerlach, G.M. Wilson, S.P.C. Cole and R.G. Deeley. Structure and expression of the mRNA encoding the murine multidrug resistance protein (MRP), an ATP-binding cassette transporter. Mol. Pharmacol. 49: 962-971 (1996).
  10. S.P.C. Cole and R.G. Deeley. Multidrug resistance associated with overexpression of MRP. In, Drug Resistance (ed. W.N. Hait). Chapter 2, pp. 39-62, Kluwer Academic Press, Norwell, MA (1996). [Cancer Treat Res. 87: 39-62, 1996] (invited).
  11. D.R. Hipfner, K.C. Almquist, B.D. Stride, R.G. Deeley and S.P.C. Cole. Location of a protease- hypersensitive region in the Multidrug Resistance Protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res. 56: 3307-3314 (1996).
  12. D. Lautier, Y. Canitrot, R.G. Deeley and S.P.C. Cole. Multidrug resistance mediated by the Multidrug Resistance Protein (MRP) gene. Biochem. Pharmacol. 52: 967-977 (1996). (Among top 1% articles cited in Biochem. Pharmacol. 1996-2006).
  13. M. Gao, D.W. Loe, C.E. Grant, S.P.C. Cole and R.G. Deeley. Reconstitution of ATP-dependent LTC4 transport by co-expression of both half-molecules of human MRP in insect Sf21 cells. J. Biol. Chem. 271: 27782-27787 (1996).
  14. Y. Canitrot, I. Neverova, A.J. Stewart, N.M. Dean, C.F. Bennett, R.G. Deeley and S.P.C. Cole. MRP-associated multidrug resistance and its reversal by 2'-modified antisense oligonucleotides. Anti-Cancer Drugs 7 (suppl 3): 93-99 (1996).
  15. B. Savas, S.P.C. Cole, T. Tsuruo and H.F. Pross. P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma. J. Clin. Immunol. 16: 348-357 (1996).